Hyperbilirubinemia in pazopanib- or sunitinib-treated patients in COMPARZ is associated with UGT1A1 polymorphisms
| Autor: | Motzer, R.J., Johnson, T., Choueiri, T.K., Deen, K.C., Xue, Z., Pandite, L.N., Carpenter, C., Xu, C.F. |
|---|---|
| Zdroj: | In Annals of Oncology November 2013 24(11):2927-2928 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|